| 摘要 |
This invention relates to diagnosis of essential thrombocythemia. More specifically, this invention provides methods of diagnosing essential thrombocythemia by detecting a decrease in gene expression or protein levels of type 3 17beta-hyrdroxysteroid dehydrogenase, and an increase in gene expression or protein levels of type 12 17beta-hyrdroxysteroid dehydrogenases, in a test subject.
|
